search
Back to results

Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie. (SENSE)

Primary Purpose

Colon Cancer, Lymphatic Metastasis

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Sentinel node mapping
Sponsored by
Ismail Gögenür
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colon Cancer focused on measuring Sentinel node mapping, lymphatic mapping, lymphatic metastasis, Aberrant lymphatic drainage, indocyanine green, ICG, near infrared, colon cancer, laparoscopic surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male and female patients above 18 years of age scheduled for laparoscopic colon cancer surgery in the department of Surgery, Herlev Hospital or Roskilde Hospital.

Exclusion Criteria:

  • iodine allergy
  • Poor kidney function (as it imply an increased risk of allergic reaction), estimated glomerular filtration rate should be above 40 ml/min.
  • Liver cirrhosis, Child-Pugh-score B and C [14]
  • Pregnancy and lactation
  • Previous anaphylactic reaction to a dye injection
  • Previous abdominal surgery

Sites / Locations

  • Herlev Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Sentinel node mapping

Arm Description

Sentinel node mapping with indocyanine green injected orally and anally to the tumor.

Outcomes

Primary Outcome Measures

Number of procedures with successful identification of sentinel nodes
Sentinel nodes is defined as the lymph node, first in line, draining from the cancer.

Secondary Outcome Measures

Number of sentinel nodes identified during surgery and their localization
Number of sentinel nodes identified by ex vivo sentinel node mapping
Malignant status of the sentinel node(s)
Malignant status of the lymph nodes
Number of cases with negative sentinel node, but positive non-sentinel node
Localization of sentinel nodes with metastasis
Localization of lymph nodes with metastasis according to D1, D2 and D3 resection lines and if they are within 1 cm from a sentinel node
Number of cases where the sentinel node procedure has changed the clinical course of the patient
if staging and oncological treatment are changed because of the procedure
Number of procedures where the procedure is stopped due to technical reasons
Registration of possible side effects occurring due to the use of indocyanine green
Number of sentinel nodes identified by only one of the sentinel node mapping techniques
Total number of lymph nodes
Localization of the identified sentinel nodes, and whether or not they are included within the normal resection lines

Full Information

First Posted
June 6, 2014
Last Updated
February 15, 2016
Sponsor
Ismail Gögenür
search

1. Study Identification

Unique Protocol Identification Number
NCT02167087
Brief Title
Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.
Acronym
SENSE
Official Title
Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
February 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ismail Gögenür

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a clinical feasibility trial that will contribute to the clarification of whether sentinel node mapping with indocyanine green (ICG) provides a better basis for staging of colorectal cancer.
Detailed Description
The patients assigned for colon cancer will be operated as planned using laparoscopic techniques and the operation follows the normal procedure, in addition a sentinel node mapping is performed. Indocyanine green is injected around the tumor by laparoscopic technique, the fluorescence is controlled and after 20 minutes the surgeon looks for sentinel nodes in a standardized manner. In the meantime, the surgeon proceeds with the operation as usual, except that the mesocolon can be resected only after sentinel node mapping has been performed. After surgery the surgeon and the pathologist inspect the resected colon together and agree on D1, D2 and D3 margins. Any marked sentinel node(s) is verified and the location is checked on the colon diagram on the case report form. In addition, an ex vivo sentinel node mapping will be performed by the pathologist right after the surgery has ended. This is done to investigate if it is the same lymph nodes there will be identified by ex vivo as by intraoperative (in vivo) sentinel node mapping. The lymph nodes in the resected colon and mesocolon are all analysed. Sentinel nodes and an equal number of randomly chosen non-sentinel nodes will be analysed further with additional sections and immune histochemistry.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Cancer, Lymphatic Metastasis
Keywords
Sentinel node mapping, lymphatic mapping, lymphatic metastasis, Aberrant lymphatic drainage, indocyanine green, ICG, near infrared, colon cancer, laparoscopic surgery

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sentinel node mapping
Arm Type
Experimental
Arm Description
Sentinel node mapping with indocyanine green injected orally and anally to the tumor.
Intervention Type
Procedure
Intervention Name(s)
Sentinel node mapping
Other Intervention Name(s)
Karl Storz ICG system, to visualize the fluorescence, Indocyanine green, PULSION medical systems., Single use aspiration needle, NA-220H-8025 from Olympus.
Intervention Description
Through transabdominal access via laparoscopic ports indocyanine green solution is injected around the tumor (25 mg indocyanine green dissolved in 9 ml sterile water and 1 ml 20% human albumin). This is done by the construction of two small boluses of 0.5 mL each into the colonic wall just orally and anally to the tumor margin, but not within the tumor itself. When the bolus is injected the fluorescence is controlled and after 20 minutes the surgeon looks for sentinel nodes in a standardized manner.
Primary Outcome Measure Information:
Title
Number of procedures with successful identification of sentinel nodes
Description
Sentinel nodes is defined as the lymph node, first in line, draining from the cancer.
Time Frame
day 1
Secondary Outcome Measure Information:
Title
Number of sentinel nodes identified during surgery and their localization
Time Frame
day 1
Title
Number of sentinel nodes identified by ex vivo sentinel node mapping
Time Frame
week 1
Title
Malignant status of the sentinel node(s)
Time Frame
week 1
Title
Malignant status of the lymph nodes
Time Frame
week 1
Title
Number of cases with negative sentinel node, but positive non-sentinel node
Time Frame
week 1
Title
Localization of sentinel nodes with metastasis
Time Frame
week 1
Title
Localization of lymph nodes with metastasis according to D1, D2 and D3 resection lines and if they are within 1 cm from a sentinel node
Time Frame
week 1
Title
Number of cases where the sentinel node procedure has changed the clinical course of the patient
Description
if staging and oncological treatment are changed because of the procedure
Time Frame
week 1
Title
Number of procedures where the procedure is stopped due to technical reasons
Time Frame
day 1
Title
Registration of possible side effects occurring due to the use of indocyanine green
Time Frame
day 1
Title
Number of sentinel nodes identified by only one of the sentinel node mapping techniques
Time Frame
week 1
Title
Total number of lymph nodes
Time Frame
week 1
Title
Localization of the identified sentinel nodes, and whether or not they are included within the normal resection lines
Time Frame
week 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female patients above 18 years of age scheduled for laparoscopic colon cancer surgery in the department of Surgery, Herlev Hospital or Roskilde Hospital. Exclusion Criteria: iodine allergy Poor kidney function (as it imply an increased risk of allergic reaction), estimated glomerular filtration rate should be above 40 ml/min. Liver cirrhosis, Child-Pugh-score B and C [14] Pregnancy and lactation Previous anaphylactic reaction to a dye injection Previous abdominal surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ismail Gögenur, Professor
Organizational Affiliation
Professor at University Hospital Køge
Official's Role
Principal Investigator
Facility Information:
Facility Name
Herlev Hospital
City
Herlev
ZIP/Postal Code
2730
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.

We'll reach out to this number within 24 hrs